These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29242901)

  • 1. Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.
    Clemens LE; Jaynes J; Lim E; Kolar SS; Reins RY; Baidouri H; Hanlon S; McDermott AM; Woodburn KW
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6273-6281. PubMed ID: 29242901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
    Mannis MJ
    Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel, Broad-Spectrum Antimicrobial Combination for the Treatment of Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M; Philbrick A; Scherzi T; Pecora N; Dunman PM; Wozniak RAF
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.
    Chojnacki M; Philbrick A; Wucher B; Reed JN; Tomaras A; Dunman PM; Wozniak RAF
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30420484
    [No Abstract]   [Full Text] [Related]  

  • 5. Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis.
    Okurowska K; Roy S; Thokala P; Partridge L; Garg P; MacNeil S; Monk PN; Karunakaran E
    J Vis Exp; 2020 May; (159):. PubMed ID: 32478743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic considerations in the treatment of bacterial keratitis.
    Callegan MC; O'Callaghan RJ; Hill JM
    Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycyrrhizin Reduces HMGB1 and Bacterial Load in Pseudomonas aeruginosa Keratitis.
    Ekanayaka SA; McClellan SA; Barrett RP; Kharotia S; Hazlett LD
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5799-5809. PubMed ID: 27792814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
    Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
    J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis.
    Li SA; Liu J; Xiang Y; Wang YJ; Lee WH; Zhang Y
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3144-50. PubMed ID: 24637683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel murine model for contact lens wear reveals clandestine IL-1R dependent corneal parainflammation and susceptibility to microbial keratitis upon inoculation with Pseudomonas aeruginosa.
    Metruccio MME; Wan SJ; Horneman H; Kroken AR; Sullivan AB; Truong TN; Mun JJ; Tam CKP; Frith R; Welsh L; George MD; Morris CA; Evans DJ; Fleiszig SMJ
    Ocul Surf; 2019 Jan; 17(1):119-133. PubMed ID: 30439473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased tolerance to commonly used antibiotics in a
    Okurowska K; Monk PN; Karunakaran E
    Microbiology (Reading); 2024 May; 170(5):. PubMed ID: 38739119
    [No Abstract]   [Full Text] [Related]  

  • 13. N-chlorotaurine and its analogues N,N-dichloro-2,2-dimethyltaurine and N-monochloro-2,2-dimethyltaurine are safe and effective bactericidal agents in ex vivo corneal infection models.
    Teuchner B; Eitzinger C; Lutz M; Hager T; Schmid E; Bechrakis NE; Zuck M; Jekle A; Debabov D; Anderson M; Nagl M
    Acta Ophthalmol; 2012 Dec; 90(8):e632-7. PubMed ID: 22971221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal Biofilms: From Planktonic to Microcolony Formation in an Experimental Keratitis Infection with Pseudomonas Aeruginosa.
    Saraswathi P; Beuerman RW
    Ocul Surf; 2015 Oct; 13(4):331-45. PubMed ID: 26220579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Salicylic Acid on the Membrane Proteome and Virulence of Pseudomonas aeruginosa.
    Bandara M; Sankaridurg P; Zhu H; Hume E; Willcox M
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1213-20. PubMed ID: 26978027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLRP12 promotes host resistance against Pseudomonas aeruginosa keratitis inflammatory responses through the negative regulation of NF-κB signaling.
    Deng QC; Deng CT; Li WS; Shu SW; Zhou MR; Kuang WB
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8063-8075. PubMed ID: 30556841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Pseudomonas aeruginosa elastase and Pseudomonas keratitis using a thiol-based peptide.
    Burns FR; Paterson CA; Gray RD; Wells JT
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2065-9. PubMed ID: 2127341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical characteristics and antibiotic susceptibility between Pseudomonas aeruginosa and P. putida keratitis at a tertiary referral center: a retrospective study.
    Cho CH; Lee SB
    BMC Ophthalmol; 2018 Aug; 18(1):204. PubMed ID: 30126384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of VIP as Treatment for Bacteria-Induced Keratitis Against Multiple Pseudomonas aeruginosa Strains.
    Carion TW; McWhirter CR; Grewal DK; Berger EA
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6932-40. PubMed ID: 26513498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombomodulin Protects Against Bacterial Keratitis, Is Anti-Inflammatory, but Not Angiogenic.
    McClellan SA; Ekanayaka SA; Li C; Jiang X; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8091-100. PubMed ID: 26720461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.